BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28076327)

  • 1. MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.
    Ke X; Yuan Y; Guo C; Yang Y; Pu Q; Hu X; Tang K; Luo X; Jiang Q; Su X; Liu L; Zhu W; Wei Y
    Oncotarget; 2017 Feb; 8(7):11356-11371. PubMed ID: 28076327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M; Liao X; Li L; Li G; Chen M
    Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
    Liu T; Wu X; Chen T; Luo Z; Hu X
    Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
    [No Abstract]   [Full Text] [Related]  

  • 5. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
    Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
    Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.
    Cai J; Fang L; Huang Y; Li R; Xu X; Hu Z; Zhang L; Yang Y; Zhu X; Zhang H; Wu J; Huang Y; Li J; Zeng M; Song E; He Y; Zhang L; Li M
    Nat Commun; 2017 Jun; 8():15870. PubMed ID: 28627514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells.
    Zhu J; Wang S; Chen Y; Li X; Jiang Y; Yang X; Li Y; Wang X; Meng Y; Zhu M; Ma X; Huang C; Wu R; Xie C; Geng S; Wu J; Zhong C; Han H
    J Nutr Biochem; 2017 Jun; 44():80-91. PubMed ID: 28431267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
    Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC.
    Wang X; Meng Q; Qiao W; Ma R; Ju W; Hu J; Lu H; Cui J; Jin Z; Zhao Y; Wang Y
    Stem Cell Res Ther; 2018 Nov; 9(1):327. PubMed ID: 30470250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
    Fan D; Ren B; Yang X; Liu J; Zhang Z
    J Exp Clin Cancer Res; 2016 Nov; 35(1):177. PubMed ID: 27846906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miR-203/SNAI2 axis regulates prostate tumor growth, migration, angiogenesis and stemness potentially by modulating GSK-3β/β-CATENIN signal pathway.
    Tian X; Tao F; Zhang B; Dong JT; Zhang Z
    IUBMB Life; 2018 Mar; 70(3):224-236. PubMed ID: 29389061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC34A2 regulates miR-25-Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell-like cells.
    Zhang L; Guo X; Zhang L; Yang F; Qin L; Zhang D; Qin Y
    Mol Carcinog; 2018 Mar; 57(3):440-450. PubMed ID: 29178392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
    Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
    Song XL; Huang B; Zhou BW; Wang C; Liao ZW; Yu Y; Zhao SC
    Biomed Pharmacother; 2018 Mar; 99():369-374. PubMed ID: 29358129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
    Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.